Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2003
04/10/2003WO2003029262A2 The human mob-5 (il-24) receptors and uses thereof
04/10/2003WO2003028759A1 Rsv gene expression vaccine
04/10/2003WO2003028750A1 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
04/10/2003WO2003028666A2 Isolated polypeptides and compositions from the venom of p. transvaalicus and methods of use
04/10/2003WO2003028659A2 Methods and compositions for modulating apoptosis
04/10/2003WO2003028654A2 Storage-stable human fibrinogen solutions
04/10/2003WO2003028632A2 Development of a preventive vaccine for filovirus infection in primates
04/10/2003WO2003028630A2 Methods and compositions for modulating interleukin-21 receptor activity
04/10/2003WO2003028621A2 Proteinase inhibitors for treating and diagnosing neurodegenerative diseases
04/10/2003WO2003028543A2 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
04/10/2003WO2003028539A2 Materials and methods for the diagnosis of pediatric tumors
04/10/2003WO2003028537A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
04/10/2003WO2003028536A2 Methods for diagnosing and treating heart disease
04/10/2003WO2003028527A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
04/10/2003WO2003028457A1 Method of restoring ciliated cell motility
04/10/2003WO2003028445A1 Tsa2306 knockout non-human animal
04/10/2003WO2003028444A1 Nonhuman mammal model of autoimmune disease having ox40l gene transferred thereinto
04/10/2003WO2003028443A1 Screening methods for agents that modulate degenerative disorders associated with bcl-2-and bim
04/10/2003WO2003028432A2 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources
04/10/2003WO2003014326A3 Isolation and mobilization of stem cells expressing vegfr-1
04/10/2003WO2003006607A9 Inhibition of apoptosis process and improvement of cell performance
04/10/2003WO2003006503A9 Chimeric g protein coupled receptors
04/10/2003WO2003006056A3 End-locked five-helix protein
04/10/2003WO2003004527A3 Novel neurotrophic factors
04/10/2003WO2003004518A3 Cortistatin analogs capable of binding selectively to growth hormone secretagogue receptors
04/10/2003WO2003003019A3 Process of purification of amyloid fibrils
04/10/2003WO2003002598A3 Peptides for use as translocation factors
04/10/2003WO2003000861A9 Eukaryotic genes involved in adult lifespan regulation
04/10/2003WO2003000855A3 Chimeric capsid proteins and uses thereof
04/10/2003WO2003000193A3 Covalent coupling of botulinum toxin with polyethylene glycol
04/10/2003WO2002101051A3 Genes and proteins for the biosynthesis of anthramycin
04/10/2003WO2002100882A3 Non-endogenous, constitutively activated versions of plant g protein-coupled receptor: gcr1
04/10/2003WO2002098911A3 Insecticidal proteins and synergistic combinations thereof
04/10/2003WO2002098448A9 Methods and compositions for modulating ace-2 activity
04/10/2003WO2002098365A3 Conditioned cell culture media and uses thereof
04/10/2003WO2002096467A3 Pharmaceutical use for secreted bacterial effector proteins
04/10/2003WO2002094859A3 Mage-a1 peptides for treating or preventing cancer
04/10/2003WO2002088752A3 Method for detecting activator or inhibitor compounds of receptors of the family of the insulin receptor using an isolated chimeric receptor
04/10/2003WO2002088360A3 Haemophilus influenzae antigens
04/10/2003WO2002086060A8 Molecular sequence of pig endogenous retrovirus receptors and methods of use
04/10/2003WO2002081509A3 Specific detection of proteolytic enzymes using a hybrid protein
04/10/2003WO2002081504A3 Multimerization of hiv-1 vif protein as a therapeutic target
04/10/2003WO2002079463A3 Methods for modification of plant inflorescence architecture
04/10/2003WO2002079251A3 Method for making human insulin precursors
04/10/2003WO2002078735A3 Leishmania vaccines
04/10/2003WO2002072826A3 Neurotrophic factors
04/10/2003WO2002070692A3 Abca9 transporter and uses thereof
04/10/2003WO2002070551A3 Neuritogenic compound and uses thereof
04/10/2003WO2002068602A8 Methods for modulating g2a receptor activity
04/10/2003WO2002062958A3 Prc17: an amplified cancer gene
04/10/2003WO2002061082A3 Zis-sr nucleic acid and amino acid sequences involved in the regulated secretory pathway and/or the regulation of the neuroendocrine phenotype (nep)
04/10/2003WO2002059311A3 Colon cancer marker
04/10/2003WO2002059282A3 Adipocyte complement related protein zacrp13
04/10/2003WO2002059260A3 Nucleic acids and polypeptides
04/10/2003WO2002055705A3 Proteins and nucleic acids encoding same
04/10/2003WO2002055688A3 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
04/10/2003WO2002054862A3 TRANSGENIC MICE CONTAINING Kv8.1 POTASSIUM CHANNEL ALPHA SUBUNIT GENE DISRUPTIONS
04/10/2003WO2002050122A3 Means for the diagnosis and therapy of ctcl
04/10/2003WO2002050107A3 Streptococcus pyogenes antigens and corresponding dna fragments
04/10/2003WO2002050104A3 Methods and cells for detecting modulators of rgs proteins
04/10/2003WO2002046406A3 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof
04/10/2003WO2002044203A3 Production of recombinant bmp-2
04/10/2003WO2002040674A3 '67118', '67067' and '62092', human proteins and methods of use thereof
04/10/2003WO2002040666A3 Fat regulated genes, uses thereof, and compounds for modulating same
04/10/2003WO2002034766A3 Peptides derived from the human amyloid precursor protein used to protect cells from iron catalyzed oxidative damage
04/10/2003WO2002029034A3 Exbb-exbd-tonb gene cluster of pseudomonas putida dot-t1e conferring tolerance to aromatic compounds and resistance to antibiotics
04/10/2003WO2002028889A3 Haemophilus influenzae antigens and corresponding dna fragments
04/10/2003WO2002026980A3 Human ion-exchanger proteins and polynucleotides encoding t he same
04/10/2003WO2002022823A3 Proteins involved in the stress response and genes from ashbya gossypii coding for the same
04/10/2003WO2002012294A3 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
04/10/2003WO2002012283A3 Disintegrin homologs, zsnk10, zsnk11, and zsnk12
04/10/2003WO2002010202A3 G-protein coupled receptors and nucleic acids encoding same
04/10/2003WO2002008396A3 Human proteases
04/10/2003WO2002003792A3 Transgenic mice containing targeted protease inhibitor gene disruptions
04/10/2003WO2002000174A3 Compositions and methods for the therapy and diagnosis of lung cancer
04/10/2003WO2001087940A3 Polypeptide composionns toxic to anthonomus insects, and use thereof
04/10/2003WO2001083693A3 Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses
04/10/2003WO2001073014A9 Human survivin interacting protein 1 (sip-1)
04/10/2003US20030070189 Transgenic corn plant for use in the generation of disease, pest, drought and stress resistant plants
04/10/2003US20030070185 Animal model for use in the generation of preferential antibodies
04/10/2003US20030070184 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
04/10/2003US20030069409 T1-R ligand III
04/10/2003US20030069408 Nucleotide sequences coding protein for use in the treatment of periodontal diseases; for use as wound healing agents
04/10/2003US20030069407 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069406 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of blood disorders
04/10/2003US20030069405 70 human secreted proteins
04/10/2003US20030069404 Nucleotide sequences coding polypeptide for use in the prevention and treatment of microorganismal infections
04/10/2003US20030069403 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069401 Osteogenic devices
04/10/2003US20030069398 Identification of human gaba transporter
04/10/2003US20030069397 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069395 Serum albumin conjugate for use in the transfer and delivery of therapeutic agent to target
04/10/2003US20030069394 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/10/2003US20030069201 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases
04/10/2003US20030069197 Probes and primers can be employed in diagnostic kits, in identifying or isolating mammalian PTTG nucleic acid, and in detecting a pathological mass associated with PTTG expression.
04/10/2003US20030069196 Ameliorating a symptom of an ischemic disorder or injury comprising administering a 200 gene product to ameliorate the symptom of the ischemic disorder or injury.
04/10/2003US20030069186 Chimeric natriuretic peptides
04/10/2003US20030069184 Oligopeptides obtained from the MUCD1 domain of the saliva mucin glycoprotein MUC7 have a net positive charge
04/10/2003US20030069181 Alternative splice forms of proteins as basis for multiple therapeutic modalities
04/10/2003US20030069180 Compositions and methods for the therapy and diagnosis of colon cancer
1 ... 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 ... 2916